Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice
Primary Care Respiratory Journal · 2004
DOI: 10.1016/j.pcrj.2003.11.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Primary Care Respiratory Journal, 2004. Verfasst von T R J Schermer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice/Family Medicine, University Medical Centre Nijmegen, 229-HAG, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. Die Arbeit wurde bisher 34-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: COPD
Abstract (Originalsprache)
OBJECTIVE: The objective of the study was to assess the probability, and explore determinants of adverse respiratory outcome after discontinuation of inhaled corticosteroid (ICS) treatment in subjects with chronic obstructive pulmonary disease (COPD) diagnosed and treated in general practice. DESIGN: Prospective unblinded ICS withdrawal study. SUBJECTS: 201 ICS treated COPD patients with various degrees of airflow limitation from 45 Dutch general practices. MAIN OUTCOME MEASURES: Probability of and time to exacerbation or unremitting worsening of respiratory symptoms after ICS discontinuation. RESULTS: Mean age was 60.6 (S.D. 9.5) years, post-bronchodilator forced expiratory volume in 1s (FEV1) 65.6 (S.D. 15.7) % predicted. Overall probability of adverse respiratory outcome after ICS discontinuation was 0.37 (95% confidence interval (CI) 0.31, 0.44). Survival analysis showed that age, gender, smoking status and reversibility of airflow limitation were independent predictors of adverse respiratory outcome. For females, the adjusted hazard ratio was 2.14 (95% CI 1.31, 3.50) compared to males. For age, the hazard ratio was 1.05 (95% CI 1.02, 1.08) per year lived. CONCLUSION: Discontinuation of inhaled corticosteroids may harm patients with COPD. The probability of an adverse respiratory outcome may be higher in women, elderly patients, smokers and patients with higher bronchodilator reversibility while on inhaled steroid treatment.
Autor:innen und Institutionen
- Department of General Practice/Family Medicine, University Medical Centre Nijmegen, 229-HAG, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Zitieren
APA
Schermer, T. R., Hendriks, A. J., Chavannes, N. H., Dekhuijzen, P. N., Wouters, E. F., van den Hoogen, H., van Schayck, C. P., & van Weel, C. (2004). Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice. Primary Care Respiratory Journal. https://doi.org/10.1016/j.pcrj.2003.11.005
Vancouver
Schermer TR, Hendriks AJ, Chavannes NH, Dekhuijzen PN, Wouters EF, van den Hoogen H, et al. Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice. Primary Care Respiratory Journal. 2004. doi:10.1016/j.pcrj.2003.11.005
BibTeX
@article{Schermer2004,
author = {Schermer, T R J and Hendriks, A J C and Chavannes, N H and Dekhuijzen, P N R and Wouters, E F M and van den Hoogen, H and van Schayck, C P and van Weel, C},
title = {Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice},
journal = {Primary Care Respiratory Journal},
year = {2004},
doi = {10.1016/j.pcrj.2003.11.005}
}
EUVIMED